Announcements Trials
Browse Landscape

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neoplasms 2Endometrial Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Carcinoma, Hepatocellular 2Adenocarcinoma of Lung 2Uterine Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Solid Tumor 1Radiomics 1Prostatic Neoplasms 1Pituitary Diseases 1Pancreatic Neoplasms 1Pancreatic Ductal Adenocarcinoma 1Neuroendocrine Tumors 1Lung Neoplasms 1Lung Diseases 1Liver Cirrhosis 1Hepatitis B 1Head and Neck Neoplasms 1Disease Progression 1Carcinoma, Squamous Cell 1Carcinoma, Renal Cell 1Carcinoma, Lobular 1Carcinoma, Ductal, Breast 1Breast Neoplasms 1Bone Neoplasms 1

Interventions

Lenalidomide 4Gemcitabine 4Dexamethasone 4Cyclophosphamide 4Bortezomib 4Nivolumab 3Cisplatin 3Carboplatin 3vandetanib 2tumor necrosis factor-alpha, CNGRC fusion protein, human 2pomalidomide 2pembrolizumab 2liposomal doxorubicin 2fludarabine 2durvalumab 2capivasertib 2Radiosurgery 2Paclitaxel 2Doxorubicin 2Bevacizumab 2Anthropogenic Effects 2venetoclax 1umbralisib 1ublituximab 1tremelimumab 1tivozanib 1ricolinostat 1regorafenib 1pazopanib 1niraparib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Disease Progression × Radiomics × Clear all
NCT03221049 2021-09-02

Radiomics for Diagnosing Liver Diseases and Evaluating Progression

Third Affiliated Hospital, Sun Yat-Sen University

Unknown
3,000 enrolled
Gastrointestinal

Hepatitis B, Carcinoma, Hepatocellular, Liver Cirrhosis, Disease Progression

Data powered by HemOnc (CC BY 4.0) Colophon âš¡